Registry for patients with deep venous obstructions
Official title: Ongoing Registry of Deep Venous Reconstructions
Run by Maastricht University Medical Center · NCT02650453 · Data updated 2026-11-12
This study collects information from patients with deep vein blockages who are getting treated with a specific procedure to see how well it works and if it's safe.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Maastricht University Medical Center Academic / other |
| Locations | 1 site (Maastricht) |
| Status | Recruiting |
| Started | September 2009 |
| Main results expected | September 2019 |
| Study ends | September 2029 |
| Registry record updated | January 8, 2016 |
| Trial ID | NCT02650453 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with venous obstruction in the femoral vein or iliac veins who experience significant symptoms.
✕Probably not a fit
Patients who are intolerant to anticoagulant medication or have a life expectancy of less than one year may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This ongoing registry collects data on patients suffering from deep venous obstructive disease who are treated using percutaneous transluminal angioplasty (PTA) and stenting, with or without surgical desobstruction of the common femoral vein. The study aims to document the effectiveness and safety of these interventions in patients with significant symptoms and confirmed venous obstruction through imaging techniques. The data is continuously updated in a digital database at a tertiary medical center, allowing for real-time analysis and insights into treatment outcomes.
Why it matters
Potential benefit: If successful, this registry could improve treatment strategies and outcomes for patients with deep venous thrombosis.
How similar studies have gone: Previous studies have shown that endovenous reconstructions are safe and effective, indicating a promising approach in this area.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Venous obstruction/occlusion in the femoral vein, common femoral vein, external iliac vein, common iliac vein or inferior vena cava Exclusion Criteria: * Intolerance to anticoagulant medication * A life expectancy \<1 year
Where it's running
-
Maastricht University Medical Centre
Maastricht, Netherlands Recruiting
Study contacts
- Principal investigator: Cees Wittens, MD, PhD — Maastricht University Medical Centre
- Study coordinator: Mark A de Wolf, MD
- Email: m.dewolf@maastrichtuniversity.nl
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treatment for cancer-associated superficial vein clots
This project will see if different blood-thinning treatments given to adults with active cancer and recent superficial vein clots lead to better outcomes.
-
Exploring the link between cancer and blood clots
This study is trying to see how cancer cells in the blood might be linked to blood clots in cancer patients and whether treatments like aspirin can help.
-
Magnetic Brain Stimulation for Pain in Small Fiber Neuropathy
This study tests whether repetitive transcranial magnetic stimulation (rTMS) can lessen pain in adults with idiopathic small fiber neuropathy.
-
DRAGON: International registry for patients who had combined portal and hepatic vein embolization before liver surgery
This registry collects data on patients who had PVE/HVE before liver resection to see if it helps liver regeneration and what factors relate to outcomes.
-
Probiotic mix to see if it boosts fullness in adults who are overweight or have obesity
A probiotic supplement is being tested in adults aged 20-70 who are overweight or have obesity to see if it makes them feel fuller and changes gut bacteria harder after 16 weeks, compared with a placebo.
-
Wearable data to spot IBD flareups in people with ulcerative colitis or Crohn's disease
This study tests whether heart‑rate variability from participants’ own wearables can help predict IBD flares.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.